期刊
LANCET NEUROLOGY
卷 9, 期 12, 页码 1182-1199出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/S1474-4422(10)70249-0
关键词
-
资金
- Higher Education Funding Council for England
- Department of Health s National Institute for Health Research Biomedical Research Centres
Management of symptoms in multiple sclerosis (MS) has received little attention compared with disease modifymg treatments However, the effect of these symptoms on quality of life can be profound Clinical trials of pharmacological drugs to treat symptoms of MS have often been underpowered and have used inappropriate measures of outcome Many currently used symptomatic drugs were introduced decades ago when study quality was considerably below current standards Therefore the evidence base on which to make clinical decisions is less than adequate Interest in pharmacological treatment of symptoms in MS has increased in recent years and several large randomised controlled trials have been reported Pharmacological strategies are a core component of the treatment of these symptoms but it is imperative to remember that a multidisciplinary rehabilitation approach is needed for effective management
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据